CEFORAN Suspension

Cefpodoxime USP

Composition : Cefpodoxime USP 40mg/5ml & 80mg/5ml Suspension.

Indication : Cefpodoxime is indicated for the treatment of- *Upper respiratory-tract infections, *Lower respiratory-tract infections, *Skin and soft tissue infections, *Uncomplicated urinarytract infections, *Sexually transmitted diseases.

Dosage and administration :

Upper respiratory-tract infections (but in pharyngitis and tonsillitis reserved for infections which are recurrent, chronic, or resistant to other antibacterial), 100mg twice daily (200mg twice daily in sinusitis) 14 days. *Lower respiratorytract infections (including bronchitis and pneumonia), 100mg to 200mg twice daily 10 days. *Skin and soft tissue infections, 200mg twice daily 7 to 14 days. *Uncomplicated urinary-tract infections 100mg twice daily 7 days. (200mg twice daily in uncomplicated upper urinary-tract infections) *Uncomplicated gonorrhea & rectal gonococcal infection in women: 200mg as a single dose Children : 15 days to 6 months: 4mg/kg every 12 hours, 6 months to 2 years : 40mg every 12 hours, 3 to 8 years : 80mg every 12 hours. Over 9 years : 100mg every 12 hours. Please see prescribing description for more information.

Use in pregnancy and lactation : Cefpodoxime has been assigned to pregnancy category B by the FDA.

Packing :

Ceforan Suspension : 50ml and 100ml suspension.

Ceforan-DS Suspension : 50ml suspension.

Prescribing Description

Related Products

© Copyright Drug International Ltd. 2021 Designed and Developed by ATI Limited.